Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katayama, M.
Right arrow Articles by Sekiguchi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katayama, M.
Right arrow Articles by Sekiguchi, K.
[Cancer Research 63, 222-229, January 2003]
© 2003 American Association for Cancer Research


Tumor Biology

Laminin {gamma}2-Chain Fragment in the Circulation

A Prognostic Indicator of Epithelial Tumor Invasion

Masahiko Katayama1, Noriko Sanzen, Akihiro Funakoshi and Kiyotoshi Sekiguchi

Diagnostic Department, Tsukuba Research Laboratories, Eisai Co., Ltd., Tsukuba, Ibaraki 300-2635 [M. K.]; Division of Gastroenterology, National Kyushu Cancer Center, Fukuoka 815-1347 [A. F.]; Institute for Protein Research, Osaka University, Suita, Osaka 565-0871 [N. S., K. S.]; and Sekiguchi Biomatrix Signaling Project, ERATO, Japan Science and Technology Corporation, Nagakute, Aichi 480-1195 [N. S., K. S.], Japan

Laminin (LN) 5, the major component of epithelial-derived extracellular matrix (ECM), plays a major role in cell adhesion and motility. Previous reports stated that proteolytic processing of the NH2-terminal region of the {gamma}2 chain enhances cell motility on LN5, indicating that the degraded {gamma}2 chain NH2-terminal region would be shed from the ECM. However, soluble LN {gamma}2 NH2-terminal fragment (G2F) have not been detected in biological fluids. Here, we developed a double-monoclonal electrochemiluminescence immunoassay for human G2F and detected its presence in the normal human circulation (mean ± SD: 39.2 ± 10.3 ng/ml; n = 10). We also measured serum levels of G2F in nude mice orthotopically transplanted with three different human pancreatic carcinoma cell lines: MIApaca-II (secreting no LN5), HPAC (secreting the {alpha}3ß3{gamma}2 heterotrimer of LN5), or KP-1 (secreting the monomeric {gamma}2 chain of LN5). Serum levels of G2F drastically increased in the nude mice transplanted with HPAC (mean ± SD: 351 ± 33 ng/ml, 5 weeks after transplantation), the most invasive tumor cells to generate extensive peritoneal dissemination in vivo. A moderate increase in serum levels of G2F was also observed in mice transplanted with KP-1 (87.9 ± 82 ng/ml, 5 weeks after transplantation), but no antigen was detected in the sera of MIApaca-II-transplanted mice. Therefore, circulating G2F was demonstrated to be a sensitive marker for LN5 production of primary pancreatic carcinomas, even if it was produced only as a monomeric {gamma}2 chain. In 11 established human pancreatic tumor cell lines (6 of LN5-producing cells and 5 of nonproducing cells), LN5-secreting cells have significantly higher levels of cell surface expression of ß4 integrin than nonsecreting cells. Thus, LN5 secretion is accompanied by cell surface expression of {alpha}6ß4 integrin, participating in hemidesmosome reorganization to form invading edges of malignant epithelial carcinomas. These data reveal that the level of circulating G2F is a new, prognostic, tumor-characterizing marker for estimating the invasiveness and malignancy of epithelial carcinomas in cancer patients.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
P. M. Carpenter, A. V. Dao, Z. S. Arain, M. K. Chang, H. P. Nguyen, S. Arain, J. Wang-Rodriguez, S.-Y. Kwon, and S. P. Wilczynski
Motility Induction in Breast Carcinoma by Mammary Epithelial Laminin 332 (Laminin 5)
Mol. Cancer Res., April 1, 2009; 7(4): 462 - 475.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. C. Lee, Y. K. Kang, W. H. Kim, Y. J. Jang, D. J. Kim, I. Y. Park, B. H. Sohn, H. A. Sohn, H. G. Lee, J. S. Lim, et al.
Functional and Clinical Evidence for NDRG2 as a Candidate Suppressor of Liver Cancer Metastasis
Cancer Res., June 1, 2008; 68(11): 4210 - 4220.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. A.B. Klemmt, J. G. Carver, P. Koninckx, E. J. McVeigh, and H. J. Mardon
Endometrial cells from women with endometriosis have increased adhesion and proliferative capacity in response to extracellular matrix components: towards a mechanistic model for endometriosis progression
Hum. Reprod., December 1, 2007; 22(12): 3139 - 3147.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Ido, A. Nakamura, R. Kobayashi, S. Ito, S. Li, S. Futaki, and K. Sekiguchi
The Requirement of the Glutamic Acid Residue at the Third Position from the Carboxyl Termini of the Laminin {gamma} Chains in Integrin Binding by Laminins
J. Biol. Chem., April 13, 2007; 282(15): 11144 - 11154.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. Takkunen, R. Grenman, M. Hukkanen, M. Korhonen, A. Garcia de Herreros, and I. Virtanen
Snail-dependent and -independent Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Cells
J. Histochem. Cytochem., November 1, 2006; 54(11): 1263 - 1275.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
T. Xiao, W. Ying, L. Li, Z. Hu, Y. Ma, L. Jiao, J. Ma, Y. Cai, D. Lin, S. Guo, et al.
An Approach to Studying Lung Cancer-related Proteins in Human Blood
Mol. Cell. Proteomics, October 1, 2005; 4(10): 1480 - 1486.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. E. Banks, A. J. Stanley, D. A. Cairns, J. H. Barrett, P. Clarke, D. Thompson, and P. J. Selby
Influences of Blood Sample Processing on Low-Molecular-Weight Proteome Identified by Surface-Enhanced Laser Desorption/Ionization Mass Spectrometry
Clin. Chem., September 1, 2005; 51(9): 1637 - 1649.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Qian, J. Niu, M. Li, P. J. Chiao, and M.-S. Tsao
In vitro Modeling of Human Pancreatic Duct Epithelial Cell Transformation Defines Gene Expression Changes Induced by K-ras Oncogenic Activation in Pancreatic Carcinogenesis
Cancer Res., June 15, 2005; 65(12): 5045 - 5053.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Gesierich, C. Paret, D. Hildebrand, J. Weitz, K. Zgraggen, F. H. Schmitz-Winnenthal, V. Horejsi, O. Yoshie, D. Herlyn, L. K. Ashman, et al.
Colocalization of the Tetraspanins, CO-029 and CD151, with Integrins in Human Pancreatic Adenocarcinoma: Impact on Cell Motility
Clin. Cancer Res., April 15, 2005; 11(8): 2840 - 2852.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.